Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (101-110 of 328) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|July 3, 1998
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanismsB K Link, S A Kostelny, M S Cole, et al.
Cancer Gene Therapy|April 4, 2023
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nucleaseStephanie Riederer, Ana Del Canizo, Javier Navas, et al.
Vaccine|August 19, 2017
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cellsEllen K Link, Christine Brandmüller, Yasemin Suezer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival of follicular lymphoma patients in the United StatesWade T Swenson, James E Wooldridge, Charles F Lynch, et al.
Leukemia & Lymphoma|July 19, 2017
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval lengthEric M Ammann, Tait D Shanafelt, Kara B Wright, et al.
Blood Neoplasia|June 2, 2025
Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphomaChristopher S Strouse, Vanessa E Siebert, Bradley T Loeffler, et al.
Cancer Causes & Control : CCC|April 25, 2006
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)Shari Chen-Hardee, Elizabeth A Chrischilles, Margaret D Voelker, et al.
Andrology|August 23, 2018
European Academy of Andrology guideline Management of oligo-astheno-teratozoospermiaG M Colpi, S Francavilla, G Haidl, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1997
Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)J P Neoptolemos, P Baker, H Beger, et al.
JAAD Case Reports|April 8, 2020
CD20<sup>+</sup> cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literatureAmanda J Tschetter, Faraaz Zafar, Margaret S Moye, et al.
Pageof 33

Showing results (101-110 of 328) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|July 3, 1998
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanismsB K Link, S A Kostelny, M S Cole, et al.
Cancer Gene Therapy|April 4, 2023
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nucleaseStephanie Riederer, Ana Del Canizo, Javier Navas, et al.
Vaccine|August 19, 2017
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cellsEllen K Link, Christine Brandmüller, Yasemin Suezer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival of follicular lymphoma patients in the United StatesWade T Swenson, James E Wooldridge, Charles F Lynch, et al.
Leukemia & Lymphoma|July 19, 2017
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval lengthEric M Ammann, Tait D Shanafelt, Kara B Wright, et al.
Blood Neoplasia|June 2, 2025
Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphomaChristopher S Strouse, Vanessa E Siebert, Bradley T Loeffler, et al.
Cancer Causes & Control : CCC|April 25, 2006
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)Shari Chen-Hardee, Elizabeth A Chrischilles, Margaret D Voelker, et al.
Andrology|August 23, 2018
European Academy of Andrology guideline Management of oligo-astheno-teratozoospermiaG M Colpi, S Francavilla, G Haidl, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1997
Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)J P Neoptolemos, P Baker, H Beger, et al.
JAAD Case Reports|April 8, 2020
CD20<sup>+</sup> cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literatureAmanda J Tschetter, Faraaz Zafar, Margaret S Moye, et al.
Pageof 33